We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Immunosuppressives and biologics during pregnancy and lactation.
- Authors
Puchner, Antonia; Gröchenig, Hans Peter; Sautner, Judith; Helmy-Bader, Yvonne; Juch, Herbert; Reinisch, Sieglinde; Högenauer, Christoph; Koch, Robert; Hermann, Josef; Studnicka-Benke, Andrea; Weger, Wolfgang; Puchner, Rudolf; Dejaco, Clemens
- Abstract
An increasing and early-onset use of immunosuppressives and biologics has become more frequently seen among patients with inflammatory bowel diseases (IBD) and rheumatic disorders. Many women in their childbearing years currently receive such medications, and some of them in an interdisciplinary setting. Many questions arise in women already pregnant or wishing to conceive with respect to continuing or discontinuing treatment, the risks borne by the newborns and their mothers and long-term safety. Together with the Austrian Society of Rheumatology and Rehabilitation, the IBD working group of the Austrian Society of Gastroenterology and Hepatology has elaborated consensus statements on the use of immunosuppressives and biologics in pregnancy and lactation. This is the first Austrian interdisciplinary consensus on this topic. It is intended to serve as a basis and support for providing advice to our patients and their treating physicians.
- Subjects
INTESTINAL diseases; HEPATOLOGY; GASTROENTEROLOGY; BIOLOGICALS; INFLAMMATORY bowel diseases
- Publication
Wiener Klinische Wochenschrift, 2019, Vol 131, Issue 1/2, p29
- ISSN
0043-5325
- Publication type
Article
- DOI
10.1007/s00508-019-1448-y